Selection criteria for treatment of rectal cancer with combined external and endocavitary radiation. 1999

E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
Section of Colon and Rectal Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

OBJECTIVE The aim of this study was to identify factors predictive of recurrence of rectal tumors treated with combined external and endocavitary radiation. METHODS Seventy-two patients with rectal cancer were evaluated clinically and with transrectal ultrasound before combined external and endocavitary radiation. Ideal lesions were moderately differentiated, mobile, not ulcerated, <3 cm in diameter, and <12 cm from the anal verge. External radiation (4,500 cGy) was given during five weeks followed by endocavitary radiation (3,000 cGy x 2). Median follow-up was 31 (range, 7-93) months. RESULTS Pretreatment transrectal ultrasound stages were uT1 (6 patients), uT2 (27 patients), and uT3 (39 patients). Clinical evaluation identified 26 ideal and 46 nonideal tumors. Overall recurrence was 36 percent; mean time to recurrence was 12 months. Ideal lesions recurred less than nonideal (15 vs. 48 percent; P = 0.01). Mobile lesions recurred less than tethered lesions (26 vs. 52 percent; P = 0.048). Transrectal ultrasound stage was predictive of recurrence (0 percent uT1, 22 percent uT2, and 51 percent uT3; P = 0.015). Surgery was possible in 14 of 17 patients with pelvic recurrence only; 11 patients (65 percent) had curative surgery. Distant metastases occurred in nine patients; all had pelvic recurrences, and six died of disease. CONCLUSIONS Patients with uT3 or nonideal rectal cancers should not be offered combined external and endocavitary radiation for cure. Transrectal ultrasound stage is the only independent predictor of recurrence.

UI MeSH Term Description Entries
D008297 Male Males
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011882 Radiotherapy, High-Energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle. Megavolt Radiotherapy,High-Energy Radiotherapy,Radiotherapy, Megavolt,High Energy Radiotherapy,Radiotherapy, High Energy
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
January 1996, Hepato-gastroenterology,
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
October 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
April 1989, Cancer,
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
January 1998, Seminars in radiation oncology,
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
November 2007, Clinical oncology (Royal College of Radiologists (Great Britain)),
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
January 2011, International journal of surgical oncology,
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
October 2001, International journal of radiation oncology, biology, physics,
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
January 2015, The Gulf journal of oncology,
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
May 1992, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E H Birnbaum, and O A Ogunbiyi, and G Gagliardi, and R D Fry, and R J Myerson, and I J Kodner, and J W Fleshman
February 1996, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!